---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-175571"
form_type: "8-K"
ticker: "SANA"
cik: "0001770121"
company_name: "Sana Biotechnology, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T18:01:07.125866+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sana Biotechnology prices $75M public offering of common stock and pre-funded warrants

## Summary
- Priced 20,895,522 shares at $3.35/share and 1,492,537 pre-funded warrants at $3.3499/underlying share.
- Gross proceeds expected ~$75M, net proceeds ~$70M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to 3,358,208 additional shares.
- Offering expected to close August 8, 2025; Morgan Stanley, Goldman Sachs, BofA, TD Cowen lead.

## SEC filing metadata
- accession: 0001193125-25-175571
- form_type: 8-K
- ticker: SANA
- cik: 0001770121
- company_name: Sana Biotechnology, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770121/000119312525175571/0001193125-25-175571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770121/000119312525175571/d83666d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-175571
- JSON: https://secwatch.observer/filing/0001193125-25-175571.json
- Plain text: https://secwatch.observer/filing/0001193125-25-175571.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.